VALERIE CAVALIERE: Open Payments
NPI 1346934528 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 30 payments from 12 companies in 2025. Trend: 2023 $243 · 2024 $909 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $171 |
| Novartis Pharmaceuticals Corporation | 4 | $109 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| BridgeBio Pharma, Inc. | 4 | $71 |
| Amgen Inc. | 3 | $52 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Vital Connect, Inc | 1 | $21 |
Products named: LEQVIO, Attruby, REPATHA, FARXIGA, LifeVest, JARDIANCE, ENTRESTO, WAINUA.
Industry payments across GA — which companies pay providers there.
